These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6323095)

  • 1. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
    Neu HC; Chin NX; Labthavikul P
    Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
    Andrew JH; Greenwood D
    J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotetan activity against Gram-negative aerobes and anaerobes.
    Moosdeen F; Maskell J; Philpott-Howard J; Williams JD
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():59-65. PubMed ID: 6601657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
    Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
    Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.
    Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Mar; 21(3):486-91. PubMed ID: 6954875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
    Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
    Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
    Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
    Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
    Fu KP; Neu HC
    J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of moxalactam to beta-lactamase.
    Richmond MH
    Rev Infect Dis; 1982; 4 Suppl():S522-6. PubMed ID: 6218561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.